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Nursing home residents are at risk for medication errors when being transferred between
wards. Medication reconciliation is a process used to verify medication use, identify vari-
ations and rectify medication errors during transitions. This pilot study was performed to
evaluate a pharmacist-directed medication-reconciliation program in a nursing home
setting. The number and types of discrepancies 3 months before (the control period) and
after (the study period) implementation of a medication-reconciliation program were
compared. A pharmacist performed medication reconciliation and discussed discrepancies
with care providers in the study period. There were 190/209 (90.9%) and 220/266 (82.7%)
documented discrepancies during the control and study periods, respectively. The major
discrepancies found in both periods were the addition or omission of drugs. Of the 46
undocumented discrepancies in the study period, 13 (28.3%) were confirmed to be inten-
tional changes. The suggestions made by the pharmacist were accepted in 19 of the
remaining 33 undocumented (and unintentional) discrepancies. Eleven of 12 harmful dis-
crepancies in the study period were corrected in a timely manner as a result of the
medication-reconciliation program, that is, 91.7% of the harmful discrepancies were suc-
cessfully prevented. But five (26.3%) harmful unintentional discrepancies of the 19 un-
documented discrepancies in the control period could not be prevented from affecting
patients. Pharmacist-directed medication reconciliation can reduce medication discrep-
ancies in a nursing home setting in Taiwan.
Copyright ª 2013, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC. Open access under CC BY-NC-ND license.1. Introduction without sufficient communication between caregivers. TheseNursing home residents are a high-risk population for unin-
tendedmedication changes if transferred to another care unital Pharmacy, School of P
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diseases. Residents in nursing homes in central Taiwan take
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homes have a higher chance of repeat hospital admissions
due to acute exacerbations of multiple chronic diseases [2].
They are thus more likely to experience unintended medica-
tion changes during their transfer to different care units [3].
Unintended medication changes are the most common
and significant type of medical errors that occur when pa-
tients are transferred [4]. Major unintended medication vari-
ations include medication omissions, incorrect route of
administration, incorrect dose and incorrect frequency of
medication given [5]. Studies have shown that more than 60%
of patients admitted to or discharged fromhospital can expect
at least one unintended medication change, with incomplete
prescription information and medication omissions being the
most common errors [2,6]. These unintended medication
changes potentially have serious medical consequences.
Medication reconciliation is a method developed to reduce
harmful unintended discrepancies, which consequently
reduce medication errors during patient transfer. It involves
verifying all medications used across institutions, identifying
variations and rectifying medication errors [5]. Studies have
shown that medication reconciliation reduces adverse drug
events at patient discharge [7]. The use of a greater number of
medications is associated with a higher frequency of dis-
crepancies during transfer between care units. Boockvar
et al’s prospective study showed an average of 3.1 discrep-
ancies during transfer for residents taking an average of 6.1
medications [3]. Multiple medications are common for most
nursing home residents. Therefore, it is necessary to imple-
ment medication reconciliation for nursing home residents
with polypharmacy during transfer. The Joint Commission on
Accreditation of Health Care Organizations (JCAHO) explicitly
recommended that one should “accurately and completely
reconcile medications across the continuum of care” as a
safety objective in 2005 [8]. Many healthcare professionals
have found this to be an effective way to avoid medication
errors.
Although JCAHO clearly identified medication reconcilia-
tion as a usefulmethod to reducemedication errors, this time-
consuming process can first be performed in populations at
riskdsuch as the elderly population. One study performed in
Sweden showed that pharmacist-directed medication-recon-
ciliation programs for those aged over 65 years can reduce the
rate of medication errors [9]. A retrospective study performed
in Belgium found discrepancies in physician-acquired medi-
cation histories that resulted in discrepancies during hospi-
talization or at discharge, and that clinical pharmacist-
conducted medication reconciliation reduced such discrep-
ancies [10]. To our knowledge, there are few related studies on
nursing home residents.
Improving the quality of care given to nursing home resi-
dents,whoaremore likely toexperienceunintendedmedication
changes due to polypharmacy and repeated hospital admis-
sions, is an important public health issue [11]. With the signifi-
cant increase in aging populations globally, the need for nursing
home care is likely to increase. In February 2009, pharmacists at
Taipei Medical UniversityeWan Fang Hospital (TMUeWFH)
began a pharmacist-implemented medication-reconciliation
programforthehospital’saffiliatednursinghomeresidents.The
purpose of this study was to evaluate the effectiveness of thisprogram. The numbers of medication variations are described,
and the types and severity of these variations were analyzed
before and after program implementation.2. Methods
2.1. Study site and subjects
The study site was a 75-bed nursing home affiliated with
TMUeWFH, a 732-bed tertiary care medical center. The
nursing home accepts patients with chronic diseases who
cannot care for themselves, patients who need care due to
rigidity and movement handicaps secondary to a neurological
disorder or musculoskeletal disease, patients with advanced
dementia, and patients with a tracheotomy, nasogastric tube,
catheter, cystostomy, or other wounds that cannot be cared
for by family members.
This study describes the frequencies and types of medi-
cation discrepancies experienced by patients who did not
receive pharmacist-directed medication reconciliation (con-
trol period: from October 2008 to January 2009) and those who
did (study period: from February to May 2009). Inclusion
criteria were new residents who were transferred to the WFH
nursing home and who stayed for more than 24 hours, WFH
nursing home residents who were transferred to WFH, or
residents returning from WFH.
During the control period, one pharmacist visited the
nursing home weekly to provide pharmaceutical care, which
included evaluating currently used medications, identifying
drug-related problems, providing suggestions to the primary
physician, and educating patients on medications. Drug-
related problems were defined as follows: lack of an indi-
cated overdose, an underdose, drugedrug interactions,
adverse drug reactions, and non-compliance with current
medications. However, the medication-reconciliation service
comparing a patient’s medication list between transfers was
not performed. Data on discrepancies between medication
lists in the nursing home and the previous institution were
collected by a retrospective analysis ofWFH inpatientmedical
charts.
During the study period, the pharmacist carried out
medication reconciliation. In addition to the weekly visit to
the nursing home, the pharmacist was informed daily of any
admission and discharge from WFH for the medication-
reconciliation program. The process of medication reconcili-
ation is shown in Fig. 1. To performmedication reconciliation,
the pharmacist compared the patient’s medications prior to
admission with the current new prescriptions. Any discrep-
ancy was recorded and classified as a dose discrepancy
(dosage differed from previous use), frequency discrepancy
(frequency differed from previous use), route discrepancy
(administration route differed from previous use), addition of
a new drug (addition of a drug not previously used), duplica-
tion, omission (deletion of a drug previously used), or substi-
tution (a switch from one medication to another with the
same treatment goal). We defined a discrepancy as any dif-
ference between the current medication orders and the pre-
vious medication history. For the control period group, the
pharmacist compared patients’ previous medications with
Contact physician
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Fig. 1 e Flowchart of the medication-reconciliation program.
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any discrepancies found.
Pharmacists made an initial evaluation to assess whether
medicationchangesweredocumentedorundocumentedbased
on patients’ medical conditions and medical records. A docu-
mented discrepancy was defined as a change in a prescription
or the reason for the change being documented in the patient’s
medical chart. If the change was undocumented, the pharma-
cist contacted the prescriber to verify whether the change was
intentional or unintentional. For unintentional discrepancies,
the pharmacist suggested a prescription modification and
recorded thephysician’s response. If thephysicianchanged the
order according to the pharmacist’s recommendation, the
discrepancy was classified as a changed discrepancy.
Unintentional discrepancies were then classified into
harmful or non-harmful. The definition of a harmful
discrepancy was that the omitted or changed prescription
could potentially cause disease deterioration in the patient
[12]; an example would be a resident with a history of atrial
fibrillation who regularly took warfarin, but the physician did
not prescribe warfarin after the patient was transferred from
the nursing home to the general ward. A non-harmful
discrepancy was defined as one that would not cause dis-
ease deterioration in the patient. After an initial evaluation
was made by the clinical pharmacist in the nursing home, a
determination of whether it was a harmful or non-harmful
discrepancy was confirmed by the pharmacy manager.
2.2. Statistical analyses
Fisher’s exact test was used to compare categorical variables
between thetwo timeperiods.TheWilcoxon rank-sumtestwasused to compare continuous variables. All statistical analyses
were performed using SPSS version 11.5 (SPSS Inc., Chicago, IL,
USA). A p value of less than 0.05 was considered significant.3. Results
This study included 18 residents in the control period group
and 20 residents in the study period group who were trans-
ferred between care units; the numbers of transfers were 25
and 28, respectively.With the exception of the average number
of medications used before transfer, there were no significant
differences in average age, length of hospital stay or number of
underlying diseases between the two groups (Table 1).
Table 2 shows the results of the analysis of medication dis-
crepancies for the control and study period groups. Thenumber
of prescriptions with a discrepancy was higher at admission
than at hospital discharge for both groups. There were 209 pre-
scriptions for the control period group, with 132 (63.2%) at
admission and 77 (36.8%) at discharge. There were 266 pre-
scriptions for the study period group, with 154 (57.9%) at
admission and 112 (42.1%) at discharge. The numbers of docu-
mented discrepancies were 190 (90.9%) for the control period
group and 220 (82.7%) for the study period group. The discrep-
ancies occurred mainly because of changes in patients’ clinical
situations.
Of the 46 undocumented discrepancies found in the study
period group, after a discussion between the pharmacist and
physicians concerned, 13 (28.3%) were determined to be
intentional discrepancies with no modification required. The
reasons for these intentional changes were: expired coverage
of the medication by health insurance or a change in the
Table 1 e Characteristics of the study population.
Study
group
Control
group
p
No. of patients 20 18
Sex
Male 13 (65) 7 (39) 0.073
Female 7 (35) 11 (61)
Age (y) 80.2  9.7 80.6  9.4 0.961
Length of stay (d) 11.9  4.8 10.9  5.7 0.171
No. of underlying diseases 5.5  1.5 5.4  2.1 0.942
Underlying disease
Old cerebral vascular accident 16 (80) 13 (72) 0.709
Hypertension 12 (60) 12 (67) 0.745
Chronic obstructive
pulmonary disease
12 (60) 8 (44) 0.516
Diabetes mellitus 10 (50) 10 (56) 0.757
Chronic heart failure 4 (20) 7 (39) 0.288
Atrial fibrillation 4 (20) 3 (17) >0.99
No. of prescribed medications
per patient
12.1  3.0 9.9  2.8 0.02
Data are presented as n (%) or mean  standard deviation.
Table 3 e Discrepancies change percentage among
undocumented discrepancies in the study and control
period groups.
Undocumented
discrepancies
Study
period
group, n (%)
Control
period
group, n (%)
p
Changed discrepancies 19 (41.3) 0 <0.01
Unchanged discrepancies 27 (58.7)a 19 (100)
Total 46 (100) 19 (100)
a Unchanged discrepancies included intentional discrepancies
and unintentional discrepancies that were not changed after
pharmacist intervention.
j o u r n a l o f f o o d and d ru g an a l y s i s 2 1 ( 2 0 1 3 ) 1 6 0e1 6 4 163clinical condition of the patient. As a result of the suggestions
made by the pharmacists, 19 of the remaining 33 undocu-
mented (and unintentional) discrepancies were modified by
physicians. The reasons for physician acceptance of the
pharmacists’ suggestions were usually related to the physi-
cians not knowing the details of patients’ previousmedication
use. Prescriptions were modified at a rate of 57.6% for unin-
tentional discrepancies and 41.3% for undocumented dis-
crepancies with pharmacist intervention (Table 3).
The frequencies of harmful discrepancies among undocu-
mented discrepancies were similar for the two groups (26.1%
for the study period group vs. 26.3% for the control period
group, respectively). Eleven of 12 harmful discrepancies in the
study period group were corrected in a timely manner as a
result of the medication-reconciliation program, that is, 91.7%
of the harmful discrepancies were successfully prevented.
Five (26.3%) harmful discrepancies of the 19 undocumented
discrepancies in the control group could not be prevented
from affecting the patients. Among unchanged discrepancies,
the incidence of harmful discrepancies was lower in the study
period group than in the control period group (7.1% vs. 26.3%).
The most common discrepancies in both groups were the
omission or addition of a new drug, on admission and atTable 2 e Discrepancies between the control and study
period groups.
Study
period
group, n (%)
Control
period
group, n (%)
p
Total number of
prescriptions
584 553
Total number of
discrepancies
266 (45.5) 209 (37.8) <0.01
Documented
discrepancies
220 (82.7) 190 (90.9) 0.01
Undocumented
discrepancies
46 (17.3) 19 (9.1)discharge (Fig. 2). For the control period group, the three most
common discrepancies were: addition of a new drug (81 of 209
cases, 38.8%), omissions (72/209, 34.4%), and substitutions (46/
209, 22.0%). For the study period group, the three most com-
mon discrepancies were: omissions (134 of 266 cases, 50.4%),
addition of a new drug (73/266, 27.4%), and substitutions (47/
266, 17.7%). It should be noted that 16 of 19 unintentional
discrepancies in the control period group and all 33 uninten-
tional discrepancies in the study period group were
omissions.4. Discussion
This study evaluated the impact of a pharmacist-directed
medication-reconciliation program for nursing home resi-
dents being transferred between care units. There was a 20%
rate of undocumented discrepancies, of whichmore than 70%
were unintentional in the study period group. Pharmacists
successfully communicated with prescribers to correct about
60% of the unintentional discrepancies, and over 90% of
potentially harmful discrepancies were prevented. The results
of this study provide evidence that a pharmacist-implemented
medication-reconciliation program can prevent potential
adverse events to nursing home residents during transfer.
The current study also found that errors of medication
omission were the most common discrepancy for the study
period group at both admission and discharge. All 19 dis-
crepancies that were modified by physicians, after accepting
the pharmacists’ recommendations, were omissions. Among
the 19 modified prescriptions, 11 were classified as harmful,
including the omission of anticoagulant and antihypertensive1 7 3
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Fig. 2 e Types and numbers of medication discrepancies.
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ciliation implemented by pharmacists can reduce the occur-
rence of adverse drug events [8,13]. From the results of this
study, it is clear that pharmacist-implemented medication
reconciliation can reduce the occurrence of harmful errors
resulting from medication omissions. This study provides
initial information to show that pharmacists can correct un-
intentional discrepancies by performing a medication-
reconciliation program, and that pharmacists can play an
important role in nursing homes.
Conducting medication reconciliation may bring additional
cost benefits. One study found that amedication-reconciliation
programresulted inmedicationcostsavingsofaboutV55.62per
patient [14]. In another study, 81 adverse drug events were
potentially averted among 290 patients through a medication-
reconciliation program. Since preventing one discrepancy in
every 290 patient encounters would offset intervention costs,
the authors concluded that theprogramwas cost-effective [15].
A cost-effectiveness study should be performed to determine if
therearecostbenefits tomedication-reconciliationprograms in
nursing homes in Taiwan.
There were some limitations to this study, including the
small samplesizeand the relatively short studyperiod.A longer
period of study with a larger sample size might show a greater
effectofpharmacist-implementedreconciliationandreduction
in the number of medication discrepancies associated with
nursing home patient transfers. Second, our study was per-
formed in a nursinghomeaffiliatedwithWFH,whose residents
tend to have more complicated conditions than non-WFH-
affiliated nursing home residents. Thus, it may not be appro-
priate to extrapolate the results of this study to other long-term
care units due to the different conditions of the residents and
prescribing patterns. However, polypharmacy is usually com-
mon in the elderly, which comprise the largest population in
long-term care units, so performing medication reconciliation
in such units may be one way of reducing medication errors.
Third, the number of prescribed medications per patient
differed between the two study period groups. The purpose of
the control period group was to show the pattern of discrep-
ancies, not to compare the effectiveness of the medication-
reconciliation program. With greater numbers in the study
period group, the number of discrepancies was indeed higher
than that of the control period group. In the future, adverse
events related to drug discrepancies in the presence and
absence ofmedication reconciliation and its cost-effectiveness
shouldbestudiedwithmatchedgroupsand larger samplesizes.5. Conclusion
The results of the current study show a reduction in unin-
tentional drug discrepancies, with a subsequent reduction inharmful discrepancies, among nursing home residents as a
result of pharmacist-directed medication-reconciliation ser-
vices provided during patient transfer between care units.
Further studies are needed with larger sample sizes and
longer-term observations to confirm these findings.r e f e r e n c e s
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